Nuria
Nuria Aguilar Izquierdo, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20080269235 | PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS - New pyridazin-3(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4. | 10-30-2008 |
20090029996 | Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors - The invention relates to new therapeutically useful pyridazin-3(2H)-one derivatives, to processes for their preparation and to pharmaceutical compositions containing them. These compounds are potent and selective inhibitors of phosphodiesterase 4 (PDE4) and are thus useful in the treatment, prevention and suppression of related pathological conditions, diseases and disorders, in particular asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, topic dermatitis, psoriasis or irritable bowel disease. | 01-29-2009 |
20090111819 | NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES - Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4: | 04-30-2009 |
20100204241 | NEW PYRIDAZIN-3(2H)-ONE DERIVATIVES - Pyridazin-3(2H)-one derivatives of formula (I) are found to inhibit PDE-4: | 08-12-2010 |
20110053936 | SUBSTITUTED SPIRO[CYCLOALKYL-1,3'-INDOL]-2'(1'H)-ONE DERIVATIVES AND THEIR USE AS P38 MITOGEN-ACTIVATED KINASE INHIBITORS - The present disclosure is directed to new inhibitors of the p38 mitogen-activated protein kinase having the general formula (I), processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof. | 03-03-2011 |
20110200557 | NEW 2-AMIDOTHIADIAZOLE DERIVATIVES - The present disclosure relates to 2-amidothiadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptors. | 08-18-2011 |
20110274657 | OXADIAZOLE DERIVATIVES AS S1P1 RECEPTOR ANTAGONISTS - The present disclosure relates to oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptor. | 11-10-2011 |
20110311485 | 1,2,4-OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE - The present disclosure relates to 1, 2, 4 oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptors. | 12-22-2011 |
Nuria Almiñana Domenech, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100247587 | PIGMENTATION-REGULATING COMPOUNDS - The present invention relates to compounds of general formula (I): | 09-30-2010 |
20110195102 | PEPTIDES USEFUL IN THE TREATMENT AND/OR CARE OF SKIN, MUCOUS MEMBRANES, SCALP AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides with general formula (I): R | 08-11-2011 |
20110305735 | SKIN ANTIAGING TREATMENT - A method for skin antiaging treatment comprising administering Botulinum toxin to an area of facial and/or neck skin, combined with the administration of a cosmetic or pharmaceutical composition comprising a cosmetically or pharmaceutically effective amount of at least one peptide derived from the SNAP-25 protein and/or at least one enkephalin-derived peptide, and at least one cosmetically or pharmaceutically acceptable excipient or adjuvant. | 12-15-2011 |
20130101662 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR HAIR AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides of general formula (I): R | 04-25-2013 |
20130309281 | SYNTHETIC PEPTIDES USEFUL IN THE TREATMENT OF THE SKING AND USE THEREOFE IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS - The present invention relates to peptides of general formula (I) capable of regulating fibrillogenesis, stereoisomers thereof and mixtures thereof, which may or may not be racemic, and the cosmetically or dermopharmaceutically acceptable salts thereof, wherein Z is alanyl, allo-isoleucyl, glycyl, isoleucyl, isoseryl, isovalyl, leucyl, norleucyl, norvalyl, prolyl, seryl, threonyl, allo-threonyl or valyl; n and m may vary between 1 and 5; AA is selected from the group consisting of natural amino acids encoded in their L- or D-form and non-encoded amino acids; x and y may vary between 0 and 2; R | 11-21-2013 |
Nuria Almiñana Domenech, Gava-Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100021510 | NEURONAL EXOCYTOSIS INHIBITING PEPTIDES - The invention relates to peptides of general formula (I): | 01-28-2010 |
Nuria Almiñana Domenech, Gava-Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100021510 | NEURONAL EXOCYTOSIS INHIBITING PEPTIDES - The invention relates to peptides of general formula (I): | 01-28-2010 |
Nuria Basora, Sherbrooke CA
Patent application number | Description | Published |
---|---|---|
20110301227 | PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS - This application relates to the use of agents such as expression vectors and nucleic acids encoding integrins α6A or α6B as well as antibodies specific for those integrins which are capable of modulating the ratio between the B and A isoforms of the α6 integrin in the treatment of diseases associated with an altered proliferation rate, such as cancer. The application also relates to the use of the ratio between the B and A isoforms of the α6 integrin in the diagnosis of diseases associated with an altered proliferation rate. | 12-08-2011 |
20150276743 | PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS - The present disclosure relates to the use of the ratio between the B and A isoforms of the α6 integrin in the diagnosis of diseases associated with an altered proliferation rate, such as cancer (especially a cancer of the gastro-intestinal track), in humans. | 10-01-2015 |
Nuria Bonastre Gilabert, Barbera Del Vall ES
Patent application number | Description | Published |
---|---|---|
20080207933 | QUATERNARY SURFACTANTS - Quaternary surfactants of the formula (I), | 08-28-2008 |
Nuria Brunet Garcia, Lleida ES
Patent application number | Description | Published |
---|---|---|
20150352139 | COMBINATION OF ANTICHOLESTEROLEMIC FIBER - The present invention relates to fiber compositions comprising fiber derived from onion and soluble fiber. Additionally, the invention relates to food products comprising said fiber compositions. In another aspect, the invention relates to methods for obtaining said fiber compositions as well as to the cosmetic uses and therapeutic uses thereof in the treatment and/or prevention of metabolic diseases, colon cancer and bowel inflammation. | 12-10-2015 |
Nuria Busquets Baque, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090198064 | Process for preparing quinuclidinium carbamate derivatives - A new process for preparing carbamate derivatives having the structure of formula (I) | 08-06-2009 |
20090299042 | PROCESS FOR MANUFACTURING 3(R)-(2-HYDROXY-2,2-DITHIEN-2-YLACETOXY)-1-(3-PHENOXYPROPYL)-1-AZONIABICY- CLO[2.2.2]OCTANE BROMIDE - This present disclosure relates to a process for manufacturing 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide by reacting 2-hydroxy-2,2-dithien-2-ylacetic acid 1-azabicyclo[2.2.2]oct-3(R)yl ester and 3-phenoxypropyl bromide, wherein the reaction takes place in a solvent or mixtures of solvents having a boiling point from 50° C. to 210° C. and chosen from ketones and cyclic ethers. | 12-03-2009 |
20100249420 | Process for preparing quinuclidinium carbamate derivatives - A new process for preparing carbamate derivatives having the structure of formula (I) | 09-30-2010 |
Nuria Campillo Martin, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100152213 | COMPOUND THAT IS A DUAL INHIBITOR OF ENZYMES PDE7 AND/OR PDE4, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF - The invention relates to a series of dual inhibitors of enzymes PDE7 and PDE4, having formula (I) and to the use thereof in the production of pharmaceutical compositions for the treatment of inflammatory and/or autoimmune processes. | 06-17-2010 |
Nuria Carbajal Navarro, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110251123 | ORAL PHARMACEUTICAL COMPOSITION OF DESMOPRESSIN - The present invention relates to a liquid oral pharmaceutical composition of desmopressin, and its use for the treatment of central diabetes insipidus, primary nocturnal enuresis, bleeding in patients with Hemophilia A, with von Willebrand-Jürgens disease and postoperative bleeding. | 10-13-2011 |
Nuria Carrillo-Carrasco, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20140271615 | HYPOSIALYLATION DISORDERS - Methods are disclosed for diagnosing a hyposialylation disorder. Methods are also disclosed for determining the effectiveness of a therapeutic agent for treatment of a hyposialylation disorder in a subject. These methods include measuring an amount of monosialylated Thomsen-Friedenreich (ST) antigen and measuring an amount of non-sialylated Thomsen-Friedenreich antigen (T) in a biological sample, such as a serum or plasma sample from the subject and determining the ratio of T to ST. A ratio of T to monosialylated ST of about 0.06 or higher diagnoses the hyposialylation disorder or indicates that the therapeutic agent is not effective for the treatment of the hyposialylation disorder. In other embodiments, a ratio of T to ST less than about 0.06 indicates that the therapeutic agent is effective for the treatment of the hyposialylation disorder, or the subject does not have the hyposialylation disorder. In additional embodiments, these methods can be used to determine the lowest effective dosage of the therapeutic agent of use to treat the subject. | 09-18-2014 |
20160025717 | HYPOSIALYLATION DISORDERS - Methods are disclosed for diagnosing a hyposialylation disorder. Methods are also disclosed for determining the effectiveness of a therapeutic agent for treatment of a hyposialylation disorder in a subject. These methods include measuring an amount of monosialylated Thomsen-Friedenreich (ST) antigen and measuring an amount of non-sialylated Thomsen-Friedenreich antigen (T) in a biological sample, such as a serum or plasma sample from the subject, and determining the ratio of T to ST. | 01-28-2016 |
Nuria Cases Porcel, Palma De Mallorca ES
Patent application number | Description | Published |
---|---|---|
20090246323 | Isotonic Energy Drink - Enriched with antioxidant nutrients, mostly liposoluble, fibre and certain micro-elements and hydrosoluble vitamins, comprises almond milk. The procedure for obtaining said drink involves a first stage of blanching the almonds; a second crushing stage; a third stage in which fruit juices or teas are added; a fourth stage in which the mixture is sterilised or pasteurised; a fifth stage in which the loss of nutrients is corrected and a final stage in which the pH and osmolality are adjusted. | 10-01-2009 |
20110293787 | ISOTONIC ENERGY DRINK - The present invention relates to an isotonic energy drink with an osmolality value between 240 and 300 per litre of drink, comprising the following components: | 12-01-2011 |
Nuria Chinchilla Salcedo, Puerto Real ES
Patent application number | Description | Published |
---|---|---|
20110059850 | PHYTOTOXIC HALOGENATED DERIVATIVES OF BENZOXAZINONES - The invention relates to phytotoxic halogenated derivatives of benzoxazinones. The aim of the invention relates to the production of novel phytosanitary products that are suitable for agricultural weed control, based on natural chemical substances. The invention comprises novel chemical compounds having high levels of phytotoxic activity and the preparation methods thereof. Said substances are derived from natural products with the 1,4-benzoxazin-3-one skeleton involved in different chemical defense interactions in plants. The inventive compounds have suitable phytotoxic activity levels for use in weed control and for use as stable models for the development of novel phytosanitary products based on the 1,4-benzoxazin-3-one skeleton. | 03-10-2011 |
Nuria Cubel Suñé, San Cugat Del Valles ES
Patent application number | Description | Published |
---|---|---|
20120283262 | PHARMACEUTICAL COMPOSITIONS COMPRISING SIGMA RECEPTOR LIGANDS - The present invention relates to a pharmaceutical composition that comprises a compound of formula (I) as active pharmaceutical ingredient: | 11-08-2012 |
Nuria De Las Heras-Rodriguez, Greater Manchester GB
Patent application number | Description | Published |
---|---|---|
20140231355 | TREATMENT OF CONTAMINATED LIQUIDS - Apparatus and method for the treatment of a contaminated liquid to remove contaminants from said liquid. The apparatus comprises a bed of a carbon based adsorbent material capable of electrochemical regeneration, at least one pair of electrodes operable to pass an electric current through said bed to regenerate the adsorbent material, and means to admit contaminated liquid into said bed to contact said adsorbent material at a flow rate which is sufficiently high to pass the liquid through the bed but below the flow rate required to fluidise the bed of adsorbent material. | 08-21-2014 |
Nuria Diaz Buezo, Alcobendas ES
Patent application number | Description | Published |
---|---|---|
20120214784 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS - An ORL-1 receptor antagonist of the formula: its uses, and methods for its preparation are described. ORL-1 antagonists are deemed to be useful in the treatment of depression and/or the treatment of overweight, obesity, and/or weight maintenance post treatment for overweight or obesity. Certain compounds have also demonstrated through animal models that the compounds of the present invention are useful for the treatment of migraines. | 08-23-2012 |
Nuria Diaz Buezo, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110118251 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS - An ORL-1 receptor antagonist of the formula: | 05-19-2011 |
20150284404 | NOVEL BENZYL SULFONAMIDE COMPOUNDS USEFUL AS MOGAT-2 INHIBITORS - The present invention provides compounds of Formula I. Wherein R1, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridemia, using the compounds. | 10-08-2015 |
Nuria Diaz Contador, Fustinana ES
Patent application number | Description | Published |
---|---|---|
20130112240 | POLAR-AXIS SOLAR TRACKER - The present invention relates to a polar-axis solar tracker comprising a series of rows of photovoltaic modules arranged on support structures formed by stringers and longitudinal shafts, wherein the support structures of the rows of photovoltaic modules are articulated in rotating assembly by means of hinges which establish an axis of rotation parallel to the shaft of said support structures of the photovoltaic modules, having an operating system which actuates the longitudinal movement of a bar, which actuates the pivoting rotation of the support structures of the photovoltaic modules on the corresponding hinges and through the connecting rods. | 05-09-2013 |
Nuria Espallargas, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20150307980 | THERMAL SPRAYING OF CERAMIC MATERIALS - A process for thermally spraying metal oxide coated ceramic particles onto a substrate comprising: (i) obtaining a plurality of metal oxide coated particles of silicon carbide, silicon nitride, boron carbide or boron nitride; and (ii) thermally spraying the particles of step (I) onto a substrate. | 10-29-2015 |
Nuria Esteban Vares, Aranjuez (madrid) ES
Patent application number | Description | Published |
---|---|---|
20100177769 | Method and Arrangement For Handling Profiles in a Multimedia Service Network - A method and apparatus for sharing an application profile for plural public IMS identities across different IMS subscriptions. A home application profile for a first public IMS identity (IMPUx) of a first IMS subscription, is stored in its entirety at a first HSS storage. A profile reference is stored as an abbreviated foreign application profile for a second public IMS identity (IMPUy) of a second IMS subscription at a second HSS storage. The profile reference points to the home application profile in the first HSS storage. An authorizing identifier for the second public IMS identity that authorizes access to the home application profile, is also stored at the first HSS storage. | 07-15-2010 |
20110075658 | HANDLING OF TERMINATING CALLS FOR A SHARED PUBLIC USER IDENTITY IN AN IP MULTIMEDIA SUBSYSTEM - A single IMPI is determined, allowing the progress of a terminating call that addresses a given IMPU shared by more than one IMPI of an IMS subscription. A number of policies are applied per IMPI basis on how to progress the terminating call. A HSS is provided where the policies are configured and, a method is disclosed including IMPU with a number of policies. Additionally, the method may also include a step of configuring at the HSS the more than one IMPI with a priority indication usable to set the order in which the more than one IMPI are checked to determine at least one for which the policies allow to progress the terminating call. | 03-31-2011 |
20110090903 | PROVIDING LOCATION INFORMATION IN AN IP MULTIMEDIA SUBSYSTEM NETWORK - A method and apparatus for providing location information to a CSCF in an IMS network. An S-CSCF registers a first contact associated with an IMPU, and receives location information associated with the first contact. A second contact associated with the same IMPU, and also with a mobile access, is then registered at the S-CSCF. The S-CSCF receives location information associated with the second contact. | 04-21-2011 |
20110310888 | Methods and Apparatuses for Handling Public Identities in an Internet Protocol Multimedia Subsystem Network - The present invention concern methods and apparatuses for handling public identities in an Internet Protocol Multimedia Subsystem, IMS, network. A Serving Call Session Control Function, S-CSCF, node receives a message including a public identity. If the message does include a profile key with a wildcarded identity, the S-CSCF uses the wildcarded identity received with the profile key to fetch a user/service profile related to the wildcarded identity. If the message does not include a profile key with a wildcarded identity, the S-CSCF | 12-22-2011 |
20110310889 | Methods and Apparatuses for Handling Public Identities in an Internet Protocol Multimedia Subsystem Network - The present invention concern methods and apparatuses for handling public identities in an Internet Protocol Multimedia Subsystem, IMS, network. A CSCF node receives information indicating a set of distinct public identities, within a range of a wildcarded public identity, which set of distinct public identities are not in the same Implicit Registration Set (IRS) as the wildcarded public identity. The information is received from a Home Subscriber Server (HSS) node. The CSCF node stores the information indicating the set of distinct public identities, which are not in the same IRS, in the CSCF node for allowing matching of an originating request to the information indicating the set of distinct public identities, which are not in the same IRS. Alternatively, the CSCF node forwards the information indicating the set of distinct public identities, which are not in the same IRS, to another CSCF node, for allowing matching of an originating request to the information indicating the set of distinct public identities, which are not in the same IRS. | 12-22-2011 |
20120036270 | IP Multimedia Subsystem User Identity Handling - A method of handling IP Multimedia Public Identity registration within an IP Multimedia Subsystem network. The method comprises receiving at a Call Session Control Function a SIP REGISTER message including a completed IP Multimedia Public Identity Attribute-Value-Pair and no IP Multimedia Private Identity. The method further comprises deriving at the Call Session Control Function an IP Multimedia Private Identity using the IP Multimedia Public Identity and sending a Cx query from the Call Session Control Function to a Home Subscriber Server, the query including the IP Multimedia Public Identity and the derived IP Multimedia Private Identity. The Home Subscriber Server identifies a subsubscription using the IP Multimedia Public Identity, and determines that the derived IP Multimedia Private Identity is not associated with said subscription. The HSS the identifies a default IP Multimedia Private Identity associated with subscription associated with said subscription, and returns a Cx response to said Call Session Control Function including said default IP Multimedia Private Identity. The Call Session Control Function uses the received, default IP Multimedia Private Identity to further handle said SIP message. | 02-09-2012 |
20120124156 | Method And Apparatus For Handling Subscriptions To Changes In User Data In A Telecommunications System - There is provided a method for handling subscriptions from a subscriber node ( | 05-17-2012 |
20120203879 | Methods and Apparatuses for Handling Public Identities in an Internet Protocol Multimedia Subsystem Network - The present invention concern methods and apparatuses for handling public identities in an Internet Protocol Multimedia Subsystem, IMS, network. According to a method an HSS receives a request message from an S-CSCF. The request message includes a public identity. The HSS sends a response message including the registered wildcarded public identity to the S-CSCF if the request message includes an indication that the public identity is unregistered, the request message does not include a wildcarded public identity indication, and the public identity, included in the request message, matches with a wildcarded public identity, registered in the HSS. The S-CSCF is thus enabled to fetch a user profile using the wildcarded public identity. | 08-09-2012 |
20150024741 | Service Profile Handling in the IMS - A Home Subscriber Server for handling IP Multimedia Subsystem subscriptions comprises means for maintaining associations between public user identities and Service Profiles, where two or more public user identities can be associated with a common Service Profile, and means for identifying to a network node all public user identities that are associated with a common Service Profile. | 01-22-2015 |
Nuria Esteban Vares, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100050234 | Provision of Access Information in a Communication Network - A method and apparatus for providing user access information to a Home Subscriber Server (HSS) in an IP Multimedia Subsystem (IMS) network. A User Equipment transmits to a Call Session Control Function (CSCF), a message containing a P-Access-Network-Info (PANI) header. The CSCF or an Application Server then sends user access information retrieved from the PANI header to the HSS, which stores the information. The stored information can be used to control access to the IMS network based on the access network being utilized or the user location. | 02-25-2010 |
Nuria Fondevilla Sala, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20120104765 | DEVICE FOR GENERATING ELECTRIC POWER FROM SMALL MOVEMENTS - This invention describes a device for the generation of electric energy from small movements which comprises: a magnet with the shape of a solid of revolution which comprises at least a couple of poles (N, S) placed around an axis of revolution; a tube whose transversal section is complementary to the shape of the magnet, and which comprises a winding rolled transversally around it, with the magnet placed in the interior of the tube so that an inclination of the tube causes the magnet to roll, traveling along the interior of the tube and inducing tension on the winding. | 05-03-2012 |
Nuria Garcia-Alonso, Muenchen DE
Patent application number | Description | Published |
---|---|---|
20120308465 | METHOD FOR PRODUCING TRICHLOROSILANE BY THERMAL HYDRATION OF TETRACHLOROSILANE - Efficient production of trichorosilane from tetrachlorosilane and hydrogen is effected by reaction at high temperatures over short residence times followed by rapidly cooling the product mixture in a heat exchanger, recovered heat being employed to heat the reactant gases, which are then fed to the reactor in a heated state. | 12-06-2012 |
Nuria Garcia-Araez, Southampton GB
Patent application number | Description | Published |
---|---|---|
20130199673 | PROCESS TO PREPARE METAL NANOPARTICLES OR METAL OXIDE NANOPARTICLES - The invention is directed to a process to prepare metal nanoparticles or metal oxide nanoparticles by applying a cathodic potential as an alternating current (ac) voltage to a solid starting metal object which solid metal object is in contact with a liquid electrolyte comprising a stabilising cation. The invention is also directed to the use of the nanoparticles as a catalyst. | 08-08-2013 |
Nuria García García, Madrid ES
Patent application number | Description | Published |
---|---|---|
20140031455 | METHOD FOR PRODUCING A COMPOUND BASED ON PSEUDOLAMINAR SILICATES AND THE USE THEREOF AS A FILLER FOR POLYMERIC MATERIALS - The present invention relates to a method for producing a compound that comprises a pseudolaminar silicate of natural origin, which is at least one clay of the paligorskite-sepiolite group, characterized in that said method comprises the following steps: defibrillating the microfibre bundles of the at least one clay in water; dispersing the defibrillated clay in an organic or inorganic liquid solvent until a stable gel is formed; adding to the dispersion at least one clay-surface-modifying agent; removing the solvent from the dispersion by means of a solid-liquid separation process and/or drying process; and deagglomerating the final compound until a powdered product is obtained. A further object of the present invention is the compound that can be obtained using said method, as well as the use of the compound as an additive or filler in composite polymeric materials in order to enhance the properties thereof, the composite polymeric material likewise being encompassed within the present invention. | 01-30-2014 |
Nuria Garcia Gonzalez, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20080233192 | Tablets with Improved Dissolution Profile - The present disclosure relates to tablets obtainable by compression of a mixture comprising at least 5% by weight of a diluent and granules which comprise a very slightly soluble drug, wherein the granules consist of a core of saccharose beads having (prior to coating) a mean particle size greater than 150μ and a coating layer comprising the very slightly soluble drug and at least one film-forming substance of high-molecular weight, as well as a process for manufacturing such tablets wherein the granules consist of a core saccharose beads having (prior to coating) a mean particle size greater than 150μ and a coating layer comprising the very slightly soluble drug and at least one film-forming substance of high-molecular weight for the manufacture of tablets by compression of a mixture comprising said granules and at least 5% by weight of a diluent. | 09-25-2008 |
20120003183 | ADDITION SALTS OF TROMETHAMINE WITH AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS - The present disclosure is directed to novel crystalline addition salts of (i) tromethamine with (ii) an azabiphenylaminobenzoic acid derivatives of formula (I), pharmaceutically acceptable solvates thereof, pharmaceutical combinations thereof, and methods of treatment. | 01-05-2012 |
20120003184 | SODIUM SALT OF 5-CYCLOPROPYL-2-BENZOIC ACID AS DHODH INHIBITOR - The present disclosure is directed to the sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid, pharmaceutically acceptable solvates thereof, pharmaceutical combinations thereof, and methods of treatment. | 01-05-2012 |
Nuria Garcia Sanz, Alicante ES
Patent application number | Description | Published |
---|---|---|
20110300199 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR SCALP AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides of general formula (I): R | 12-08-2011 |
20120021029 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides of general formula (I): | 01-26-2012 |
20120121675 | COMPOUNDS WHICH INHIBIT MUSCLE CONTRACTION - Peptides of general formula (I): R | 05-17-2012 |
Nuria Godessart Marina, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110129445 | COMBINATIONS COMPRISING METHOTREXATE AND DHODH INHIBITORS - The present disclosure relates to combinations comprising (a) methotrexate, and (b) a DHODH inhibitor and their uses. | 06-02-2011 |
20110280831 | COMBINATIONS COMPRISING METHOTREXATE AND DHODH INHIBITORS - The present invention provides a combination which comprises (a) methotrexate and (b) a non-hepatotoxic DHODH inhibitor of formula (I): wherein: R | 11-17-2011 |
Nuria Gonzalez Fernandez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110212434 | NOVEL HIV-BASED RECOMBINANT VIRAL CLONES AND USE THEREOF IN ANALYTICAL METHODS - The present invention refers to HIV-based recombinant viral clones that possess the general structure represented in FIG. | 09-01-2011 |
Nuria Gonzalez Martinez, Alacuas (valencia) ES
Patent application number | Description | Published |
---|---|---|
20130035291 | OBTAINMENT OF BIOACTIVE PRODUCTS FROM COCOA HAVING INHIBITORY ACTIVITY AGAINST THE PEP ENZYME AND ANTIOXIDANT AND/OR ANTINEURODEGENERATIVE ACTIVITY - The present invention relates to the production of bioactive products from raw plant matter, namely cocoa extracts. The said products have one or more biopeptides with prolyl endopeptidase (PEP) enzyme inhibitory activity in vitro and/or antioxidant and/or antineurodegenerative capacity in vivo and can be used in dietetics and in the food and pharmaceutical industries. | 02-07-2013 |
Nuria Gonzalez Martinez, Alaquas ES
Patent application number | Description | Published |
---|---|---|
20130078187 | Method for Selecting Bacteria with Anti-Oxidant Action - The present invention relates to a method using | 03-28-2013 |
Nuria Gonzalez-Montalban, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20130115637 | Efficiency of Prion Conversion in vitro and Sensitivity of Prion Detection - The present invention relates to improved methods and kits for the amplification detection of pathogenic prion proteins in samples. In some aspects of the invention, the method comprises: i) contacting the sample with a source of PrP | 05-09-2013 |
Nuria Granados Borbolla, Palma De Mallorca ES
Patent application number | Description | Published |
---|---|---|
20150182597 | COMPOSITIONS COMPRISING HYALURONIC ACID AND DERMATAN SULPHATE FOR THE TREATMENT OF BEING OVERWEIGHT AND OBESITY - The present invention relates to a composition comprising hyaluronic acid and dermatan sulphate for use in the treatment or prevention of overweight, obesity, insulin resistance, type 2 diabetes, fatty liver or dyslipidemia or for use in reducing food intake, inducing the feeling of satiety, reducing appetite, reducing body weight, preventing weight gain, reducing body fat, reducing fat formation, reducing blood cholesterol, maintaining normal blood cholesterol levels, reducing blood triglycerides, maintaining normal blood triglyceride levels or increasing insulin sensitivity. The composition can further contain collagen hydrolysate. The composition can be in the form of a pharmaceutical composition, a food, a functional food, a medical food or a food supplement. | 07-02-2015 |
Nuria Izquierdo Useros, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20140370052 | INHIBITORS OF SIALOADHESIN FOR THE TREATMENT OF DISEASES CAUSED BY ENVELOPED VIRUSES - The present invention refers to methods and compositions to prevent viral entry into cells expressing the CD169/sialoadhesin surface receptor by inhibiting the coupling of the sialyllactose molecule contained in the viral membrane gangliosides to the CD 169/sialoadhesin receptor. The invention also pertains to vaccine compositions based on dendritic cells loaded with an antigen of interest whereby the vaccine is provided together with a composition capable of preventing viral entry into cells expressing the CD169/sialoadhesin. Moreover, the invention relates to diagnostic and therapeutic compositions that can be specifically delivered to enveloped virions wherein the diagnostic/therapeutic agent is coupled to CD169/sialoadhesin. | 12-18-2014 |
Nuria Jomet, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100026748 | PRINTHEAD AND METHOD OF PRINTING - A printhead for a printer in which a print medium advances in a media advance direction, said printhead being static when printing and having an adjustable length in a width direction that is perpendicular to said media advance direction, such that the length of the printhead in said width direction can be adjusted to the width of the image to be printed. | 02-04-2010 |
Nuria Jornet, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110279506 | BI-DIRECTIONAL COLOR PRINTING - A source image is converted to a printable image that is constrained to a bi-directional gamut achievable by both a forward-first print mode and a reverse-first print mode. While the printable image is printed, a print system alternates between forward and reverse passes. The print system uses a forward-first color map during the forward passes and a different reverse-first color map during the reverse passes. | 11-17-2011 |
Nuria Llamas Castro, Savigny Sur Orge ES
Patent application number | Description | Published |
---|---|---|
20160114898 | CIRCUIT FOR DE-ICING AN AIR INLET LIP OF AN AIRCRAFT PROPULSION ASSEMBLY - Propulsion assembly, comprising a turbine engine surrounded by a nacelle comprising an annular air inlet lip, the propulsion assembly further comprising a circuit for lubricating elements of the turbine engine and a circuit for de-icing the air inlet lip, characterised in that said de-icing circuit comprises a heat exchanger comprising a primary circuit of oil supplied by said lubrication circuit and a secondary circuit of a heat transfer fluid for supplying at least one de-icing channel extending into said air inlet lip, said de-icing circuit further comprising a pump for circulating the heat transfer fluid into said at least one channel. | 04-28-2016 |
Nuria Llamas Castro, Savigny Sur Orge FR
Patent application number | Description | Published |
---|---|---|
20150204246 | DRIVE GEARBOX ON A TURBOMACHINE, CONSISTING OF A DRIVE TRAIN WITH GEAR LINES EXTENDING INTO NON-PARALLEL PLANES - This A gearbox to be mounted on a turbomachine and driven by a radial drive shaft of the latter. The gearbox has a three-dimensional or sinuous shape, which can house a large quantity of equipment to be driven, without occupying a large amount of space in any dimension, since the gearbox remains close to the turbomachine and the equipment can be distributed over a large surface. The drive train of gears successively extends into several non-parallel planes and comprises an axial branch on the turbomachine and a branch forming an arc of circle around the turbomachine. | 07-23-2015 |
20150300208 | TURBINE ENGINE HAVING AN ELEMENT FOR DEFLECTING FOREIGN OBJECTS - Turbine engine ( | 10-22-2015 |
Nuria Llombart, Madrid ES
Patent application number | Description | Published |
---|---|---|
20120013517 | INTEGRATED LENS ANTENNAS FOR MULTI-PIXEL RECEIVERS FOR PLANETARY AND ASTRONOMICAL INSTRUMENTS - Methods and apparatus for integrating lens antennas for receivers are disclosed. A method of fabricating a lens in accordance with one or more embodiments of the present invention comprises integrating lens material with a dielectric material and flowing the lens material into a desired lens shape. An integrated lens antenna in accordance with one or more embodiments of the present invention comprises a dielectric material, a waveguide feed, coupled to the dielectric material through a leaky wave cavity, and a lens, coupled to the dielectric material opposite the leaky wave cavity, wherein material is first deposited onto the dielectric material, flowed into a desired lens shape and the desired lens shape is transferred to the dielectric material. | 01-19-2012 |
Nuria Llombart, Delft NL
Patent application number | Description | Published |
---|---|---|
20140144009 | Microfabrication Technique of Silicon Microlens Array for Terahertz Applications - A set of antenna geometries for use in integrated arrays at terahertz frequencies are described. Two fabrication techniques to construct such antennas are presented. The first technique uses an advanced laser micro-fabrication, allowing fabricating advanced 3D geometries. The second technique uses photolithographic processes, allowing the fabrication of arrays on a single wafer in parallel. | 05-29-2014 |
Nuria Llombart Juan, Alboraya ES
Patent application number | Description | Published |
---|---|---|
20100328779 | DIELECTRIC COVERED PLANAR ANTENNAS - An antenna element suitable for integrated arrays at terahertz frequencies is disclosed. The antenna element comprises an extended spherical (e.g. hemispherical) semiconductor lens, e.g. silicon, antenna fed by a leaky wave waveguide feed. The extended spherical lens comprises a substantially spherical lens adjacent a substantially planar lens extension. A couple of TE/TM leaky wave modes are excited in a resonant cavity formed between a ground plane and the substantially planar lens extension by a waveguide block coupled to the ground plane. Due to these modes, the primary feed radiates inside the lens with a directive pattern that illuminates a small sector of the lens. The antenna structure is compatible with known semiconductor fabrication technology and enables production of large format imaging arrays. | 12-30-2010 |
Nuria Marti Bruna, Murcia ES
Patent application number | Description | Published |
---|---|---|
20150258225 | Apparatus For Instantaneous Expansion With Vacuum And Ultrasound Waves - This invention is based on forming an apparatus in which the technologies of flash vacuum expansion and simultaneous treatment with ultrasounds are combined for various applications in the food, pharmaceutical and cosmetics industries | 09-17-2015 |
Nuria Martínez Martín, Toledo ES
Patent application number | Description | Published |
---|---|---|
20150059938 | METHOD OF DETECTION AND REMOVAL OF AUXILIARY MATERIAL SUITABLE FOR THE MANUFACTURING OF AN AIRCRAFT ELEMENT - A method of detection and removal of auxiliary material suitable for the manufacturing of an aircraft element includes providing an auxiliary material having at least one detection label, scanning the element with a label detector suitable to detect the detection label once the element has been manufactured, detecting the auxiliary material by means of a warning signal emitted by the label detector and removing the auxiliary material from the element. An auxiliary material suitable for the manufacturing of an aircraft element includes a detection label. | 03-05-2015 |
Nuria Mata Burgarolas, Neubiberg DE
Patent application number | Description | Published |
---|---|---|
20110119650 | Method for operating a computer device - A method is provided for operating a first computer device, in which a source program code is generated which contains a functional model that is hierarchically composed of functions which are hierarchically composed of components, the visibility of the components within the functional model being determined by the hierarchy. Placeholders are used within the hierarchy for determined components and executable program code is generated, the placeholders being replaced by the determined components via a correspondingly executed mapping rule before executable program code is generated. This method allows the locality principle to be maintained, for example on experimental hardware. | 05-19-2011 |
Nuria Menéndez Sánchez, Oviedo ES
Patent application number | Description | Published |
---|---|---|
20120270823 | AUREOLIC ACID DERIVATIVES, THE METHOD FOR PREPARATION THEREOF AND THE USES THEREOF - Aureolic acid derivatives, process for obtaining them and uses thereof. This invention provides a bacterial strain that produces compound belonging to the family of aureolic acids useful in the treatment of cancer or nervous system diseases. | 10-25-2012 |
Nuria Nuria Esteban Vares, Aranjuez (madrid) ES
Patent application number | Description | Published |
---|---|---|
20100093284 | Method and apparatus for collecting user activity in a telecommunications system - Method and apparatuses for collecting user activity information in a telecommunications system. A first telecommunications node ( | 04-15-2010 |
Nuria Oliver Ramirez, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20150178626 | METHOD FOR PREDICTING REACTIVENESS OF USERS OF MOBILE DEVICES FOR MOBILE MESSAGING - A method for predicting reactiveness of MMI users comprises: | 06-25-2015 |
Nuria Oliver Ramírez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110230987 | Real-Time Music to Music-Video Synchronization Method and System - Method, system and computer program for real time synchronizing an audio file and a video file in a multimedia device. The present invention determines the optimum alignment path between the audio signal of the audio file and the audio track signal of the video file, starting from an initial path and performing a post-alignment processing to improve the user satisfaction when playing. | 09-22-2011 |
Nuria Parés Fernández, Vilanova I La Geltru ES
Patent application number | Description | Published |
---|---|---|
20120000943 | LOW HEIGHT PRECOMPRESSION PUMP - A low height precompression pump having a piston with a lower outwardly flaring lip seal and an inwardly flaring lip seal rimming a central aperture of the piston, and which may include a first elastic member housed in the cylinder and a second elastic member having an upper bearing point applied directly on the plunger rod above an upper retention cover. | 01-05-2012 |
Nuria Parés Fernández, Vilanova I La Geltru ES
Patent application number | Description | Published |
---|---|---|
20120000943 | LOW HEIGHT PRECOMPRESSION PUMP - A low height precompression pump having a piston with a lower outwardly flaring lip seal and an inwardly flaring lip seal rimming a central aperture of the piston, and which may include a first elastic member housed in the cylinder and a second elastic member having an upper bearing point applied directly on the plunger rod above an upper retention cover. | 01-05-2012 |
Nuria Parody - De La Fuente, Alcobendas ES
Patent application number | Description | Published |
---|---|---|
20140030293 | NEW ADJUVANT - The invention relates to a new adjuvant and to its use in combination with an antigen. | 01-30-2014 |
Nuria Pascual Duran, Madrid ES
Patent application number | Description | Published |
---|---|---|
20160033489 | Haptenes and Conjugates Derived from Pyocyanin, Antibodies Thereof, and Immunichemical Method for Detecting Infections Caused by Pseudomonas Aeruginosa - The present invention relates to a compound of general formula I and to the use thereof as a hapten. | 02-04-2016 |
Nuria Pelechano-Gomez, Valencia ES
Patent application number | Description | Published |
---|---|---|
20090306946 | METHODS AND SYSTEMS FOR SIMULATION AND REPRESENTATION OF AGENTS IN A HIGH-DENSITY AUTONOMOUS CROWD - This invention relates to methods and systems for simulation and representation of the behavior of individuals in a high-density autonomous crowd in response to a changing dynamic environment. | 12-10-2009 |
Nuria Reig Bolaño, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20140296188 | NEW THERAPY FOR TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS - It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of trans-thyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate. | 10-02-2014 |
Nuria Rodrigo Caballero, Madrid ES
Patent application number | Description | Published |
---|---|---|
20120101757 | DIMENSIONAL INSPECTION METHOD FOR A COMPOSITE PART - A method for performing a dimensional inspection of a fabricated composite part ( | 04-26-2012 |
20120132753 | INTERFACE ARRANGEMENT BETWEEN TWO COMPONENTS OF AN AIRCRAFT LIFTING SURFACE USING AN INTERMEDIATE PART - Interface arrangement between a first component ( | 05-31-2012 |
20120132754 | INTERFACE ARRANGEMENT BETWEEN TWO-COMPONENTS OF AN AIRCRAFT STRUCTURE - Interface arrangement between a first component ( | 05-31-2012 |
Nuria Rodriguez Garrido, Madrid ES
Patent application number | Description | Published |
---|---|---|
20140012000 | PROCESS FOR PREPARING A PROPIOLIC ACID OR A DERIVATIVE THEREOF - The invention relates to a process for preparing a propiolic acid or a derivative thereof by reacting a terminal alkyne with carbon dioxide, which comprises performing the reaction in the presence of a base and a copper complex, especially a copper (I) complex having at least one ligand, at least one of the ligands of the copper complex being selected from monodentate ligands which have an aminic or iminic nitrogen atom capable of coordination with copper, and polydentate ligands having at least two atoms or atom groups which are capable of simultaneous coordination with copper and are selected from nitrogen, oxygen, sulfur, phosphorus and carbene carbon. | 01-09-2014 |
Nuria Rodriguez Gómez, Oviedo ES
Patent application number | Description | Published |
---|---|---|
20110250550 | METHOD AND DEVICE FOR BIOMASS COMBUSTION WITHOUT CARBON DIOXIDE EMISSION - The invention relates to a device and a method for biomass combustion and simultaneous CO | 10-13-2011 |
Nuria Ruiz Xiville, Badalona ES
Patent application number | Description | Published |
---|---|---|
20150174065 | SOLID PHARMACEUTICAL COMPOSITION OF CATION EXCHANGE RESIN - The present invention relates to a solid pharmaceutical cation-exchange resin composition allowing the preparation of a stable resin suspension in an aqueous vehicle and the resin being easily resuspended in the case of sediment formation. Said composition comprises hydroxypropyl methylcellulose and pregelatinized starch as functional excipients. The invention also relates to a solid form for oral administration comprising the composition, to the use thereof for the preparation of oral solid forms, and to said composition for use in the treatment of hyperkalaemia. | 06-25-2015 |
20150306135 | ORAL PHARMACEUTICAL COMPOSITION FOR DRUGS WITH A HIGH-DOSAGE REGIMEN - The present invention relates to an oral pharmaceutical composition for drugs with a high dosage regimen, specifically, ion exchange resins and bulk-forming laxatives. Said composition comprises the combination of a liquid oily component and a texturizing agent, giving the composition good organoleptic properties that allow taking drugs with a high dosage regimen without the usual problems associated with their poor palatability. The invention also relates to a method for preparing said composition and to the use thereof for the treatment of various pathologies. Furthermore, the invention also relates to an adduct formed between a polyol and an ion exchange resin, to a method for preparing it, and to the use thereof to improve resin palatability. | 10-29-2015 |
Nuria Salazar Sánchez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130064890 | PHARMACEUTICAL FORMULATION BASED ON IBUPROFEN AND CODEINE HAVING IMPROVED STABILITY - Pharmaceutical formulation based on ibuprofen and codeine having improved stability. The invention consists of a novel pharmaceutical formulation having the form of tablets or similar comprising a core composed of an association of ibuprofen and codeine as active ingredients, together with an excipient including at least a diluent, a disintegrating agent, a fluidizing agent and a lubricant which is sodium stearyl fumarate. Said core is coated with a composition based on one or several polymers of diverse modified cellulose ethers and polymers derived from acrylic and methacrylic acids, a plasticiser and, an opacifier or colouring agent and any of the mixtures thereof. These characteristics render the tablets of the invention more efficacious and safe having the form of more stable preparations, without this fact implying greater technological complexity. | 03-14-2013 |
Nuria Salazar Sánchez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130064890 | PHARMACEUTICAL FORMULATION BASED ON IBUPROFEN AND CODEINE HAVING IMPROVED STABILITY - Pharmaceutical formulation based on ibuprofen and codeine having improved stability. The invention consists of a novel pharmaceutical formulation having the form of tablets or similar comprising a core composed of an association of ibuprofen and codeine as active ingredients, together with an excipient including at least a diluent, a disintegrating agent, a fluidizing agent and a lubricant which is sodium stearyl fumarate. Said core is coated with a composition based on one or several polymers of diverse modified cellulose ethers and polymers derived from acrylic and methacrylic acids, a plasticiser and, an opacifier or colouring agent and any of the mixtures thereof. These characteristics render the tablets of the invention more efficacious and safe having the form of more stable preparations, without this fact implying greater technological complexity. | 03-14-2013 |
Nuria Sanvicens Diez, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110136898 | TREATMENT OF RETINAL DEGENERATION - The use of a compound of general formula (I): or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of a disease or condition characterised by apoptosis or degeneration of mammalian cells, wherein: R1 is a alkoxy, alkyl, ether or ester group; R2 is H or has the formula wherein Y is linear or branched, saturated or unsaturated, aliphatic group with from 2 to 23 carbon atoms, or a cyclic group, and which can contain substituents selected from the group consisting of hydroxyl, alkoxy, amino, carboxyl, cyano, nitro, alkylsuphonyl or halogen atoms, X is O or S; and R3 is any substituent. | 06-09-2011 |
Nuria Sanz Menendez, Alcobendas ES
Patent application number | Description | Published |
---|---|---|
20150105468 | Pharmaceutical Composition of Ibuprofen and Tramadol for Ophthalmic Use - The present invention relates to a pharmaceutical composition of ibuprofen and tramadol for ophthalmic use. Said composition is effective and safe for the treatment of ocular inflammation and/or pain associated to different diseases or pathological states which affect the eye area In particular, the ophthalmic composition of the invention is indicated, for example, for the treatment of pain and/or inflammation after eye surgery. | 04-16-2015 |
Nuria Tarancon Valera, Moncada ES
Patent application number | Description | Published |
---|---|---|
20140314718 | NEW STRAIN OF BACILLUS SUBTILIS FOR COMBATING PLANT DISEASES - The present invention relates to an isolated strain of | 10-23-2014 |
Nuria Uguet Canal, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100206197 | BITUMINOUS COMPOSITION, FABRICATION PROCESS AND USE THEREOF IN ROAD ENGINEERING - The invention concerns a fabrication method of a bituminous emulsion, consisting in the use of a primary bitumen emulsion, possibly diluted, characterized by a median diameter of less than 2 μm, as aqueous phase of a secondary bitumen emulsion characterized by a median diameter of more than 2 μm, wherein the final emulsion thus obtained is characterized by a bitumen content of 50% to 95% by weight, a STV viscosity at 40 C through the 4 mm orifice of less than 300 s and a settling tendency of less than 10% as determined by means of assay EN 12847. | 08-19-2010 |
Nuria VÁzquez GarcÍa, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20160000022 | BIODEGRADABLE MULCH FOR AGRICULTURAL APPLICATIONS - Biodegradable mulch of the type used in various agricultural applications is made by multi-layer extrusion from a mixture of two compostable biodegradable polymers that comply with the EN13432 standard and that include potato starch, a black masterbatch and biodegradable recycled polymers. The mulch self-degrades in a short period of time, becoming a compostable material that enriches the soil, avoiding the collecting and cleaning tasks that are necessary in conventional mulches. | 01-07-2016 |
Nuria Vigues Frantzen, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110035157 | BIOMASS CONCENTRATION MEASUREMENT DEVICE AND METHOD AND USE OF AN ELECTRONIC CHIP ELEMENT FOR MEASURING SAID BIOMASS CONCENTRATION - The invention relates to devices and methods for measuring a concentration of a biomass suspended in a medium. Embodiments of the device include a substrate capable of being immersed in the medium, at least two electrodes integrated in the substrate, and a processing and control circuit electromagnetically coupled to the at least two electrodes. The processing and control circuit is configured to apply an electrical potential to the at least two electrodes, the applied electrical potential generating a stationary electric charge that leads to the appearance of an electrical double layer on a surface of one of the at least two electrodes and that causes a biomass electrostatic adhesion on the surface, measure a change in capacitance of the electrical double layer in response to the biomass electrostatic adhesion, and determine the concentration of the biomass using a calibration curve that correlates the change in capacitance with the concentration. | 02-10-2011 |
Núria AgullÓ Chaler, Valldoreix (barcelona) ES
Patent application number | Description | Published |
---|---|---|
20160122566 | INK COMPOSITION FOR INKJET PRINTING - The composition of the invention comprises: (a) polyethylene glycol with a molecular weight comprised between 20000 (20 K) and 50000 (50 K), at a weight/volume concentration comprised between 0.5 and 15%; (b) a non-ionic surfactant of general formula (I) where n is comprised between 5 and 40, and said surfactant being at a volume/volume concentration comprised between 0.1% and 2.0%; and (c) one or more ingredients selected from a liquid carrier, a binder and an additive suitable for printing. | 05-05-2016 |
Núria Almiñana Domenech, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100247587 | PIGMENTATION-REGULATING COMPOUNDS - The present invention relates to compounds of general formula (I): | 09-30-2010 |
20110002969 | COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING METALLOPROTEINASE INHIBITORS - Peptides of general formula (I): R | 01-06-2011 |
20110052519 | PEPTIDE DERIVATIVES USEFUL IN THE TREATMENT, CARE OR CLEANSING OF THE SKIN, MUCOSAE, SCALP OR NAILS - The invention relates to peptide derivatives of general formula (I): | 03-03-2011 |
20110300199 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR SCALP AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides of general formula (I): R | 12-08-2011 |
20120021029 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides of general formula (I): | 01-26-2012 |
20120121675 | COMPOUNDS WHICH INHIBIT MUSCLE CONTRACTION - Peptides of general formula (I): R | 05-17-2012 |
20130078295 | SKIN ANTIAGING TREATMENT - A method for skin antiaging treatment including administering Botulinum toxin to an area of facial and/or neck skin, combined with the administration of a cosmetic or pharmaceutical composition having a cosmetically or pharmaceutically effective amount of at least one peptide derived from the SNAP-25 protein and/or at least one enkephalin-derived peptide, and at least one cosmetically or pharmaceutically acceptable excipient or adjuvant. | 03-28-2013 |
20130101662 | PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR HAIR AND ITS USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides of general formula (I): R | 04-25-2013 |
20130309281 | SYNTHETIC PEPTIDES USEFUL IN THE TREATMENT OF THE SKING AND USE THEREOFE IN COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS - The present invention relates to peptides of general formula (I) capable of regulating fibrillogenesis, stereoisomers thereof and mixtures thereof, which may or may not be racemic, and the cosmetically or dermopharmaceutically acceptable salts thereof, wherein Z is alanyl, allo-isoleucyl, glycyl, isoleucyl, isoseryl, isovalyl, leucyl, norleucyl, norvalyl, prolyl, seryl, threonyl, allo-threonyl or valyl; n and m may vary between 1 and 5; AA is selected from the group consisting of natural amino acids encoded in their L- or D-form and non-encoded amino acids; x and y may vary between 0 and 2; R | 11-21-2013 |
20140086981 | PGC-1ALPHA-MODULATING PEPTIDES - Peptides of general formula (I): R | 03-27-2014 |
20140120141 | PEPTIDES USEFUL IN THE TREATMENT AND CARE OF THE SKIN AND MUCOUS MEMBRANES AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Peptides of general formula (I), their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use for the treatment and/or care of conditions, disorders and/or diseases of the skin and/or mucous membranes. | 05-01-2014 |
20150071974 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS - Compounds of general formula (I): R | 03-12-2015 |
20150098989 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS - Compounds of general formula (I): R | 04-09-2015 |
20150140046 | COMPOUNDS WHICH INHIBIT NEURONAL EXOCYTOSIS - Compounds of general formula (I): R | 05-21-2015 |
20150183823 | COSMETIC OR PHARMACEUTICAL COMPOSITIONS INCLUDING TRIPEPTIDES CAPABLE OF STIMULATING CYCLIC ADENOSINE MONOPHOSPHATE SYNTHESIS AND THEIR USE IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR - Cosmetic or pharmaceutical compositions and methods employ peptides of general formula (I): | 07-02-2015 |
20160075738 | COMPOUNDS USEFUL IN THE TREATMENT AND/OR CARE OF THE SKIN AND THEIR COSMETIC OR PHARMACEUTICAL COMPOSITIONS - Compounds of general formula (I): their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, cosmetic and/or pharmaceutical compositions which contain them and their use in medicine, and in the treatment and/or care of the skin, particularly in the aging and photoaging of the skin, and more particularly for the treatment and/or prevention of wrinkles and/or stretch marks. | 03-17-2016 |
Núria Almiñana Domenech, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110052519 | PEPTIDE DERIVATIVES USEFUL IN THE TREATMENT, CARE OR CLEANSING OF THE SKIN, MUCOSAE, SCALP OR NAILS - The invention relates to peptide derivatives of general formula (I): | 03-03-2011 |
Núria Bayo-Puxan, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100292163 | Antitumoral Compounds - Antitumoral compounds of Formula I, and pharmaceutically acceptable salts, derivatives, tautomers, prodrugs or stereoisomers thereof | 11-18-2010 |
Núria Bayo-Puxan, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100292163 | Antitumoral Compounds - Antitumoral compounds of Formula I, and pharmaceutically acceptable salts, derivatives, tautomers, prodrugs or stereoisomers thereof | 11-18-2010 |
Núria BayÓ-Puxan, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20110207674 | ANTITUMORAL COMPOUNDS - Antitumoral compounds of Formula I, and pharmaceutically acceptable salts, derivatives, tautomers, prodrugs or stereoisomers thereof | 08-25-2011 |
Núria Casals Farré, Castelldefels ES
Patent application number | Description | Published |
---|---|---|
20120251504 | PLURIPOTENT STEM CELLS OBTAINED FROM DENTAL PULP - The present invention relates to pluripotent stem cells obtained from the dental pulp of patients of different ages, the invention furthermore comprises cultures of said cells, means for obtaining them and pharmaceutical compositions comprising them, as well as their application in tissue regeneration. | 10-04-2012 |
Núria Casals FarrÉ, Castelldefels ES
Patent application number | Description | Published |
---|---|---|
20150299661 | PLURIPOTENT STEM CELLS OBTAINED FROM DENTAL PULP - The present invention relates to pluripotent stem cells obtained from the dental pulp of patients of different ages, the invention furthermore comprises cultures of said cells, means for obtaining them and pharmaceutical compositions comprising them, as well as their application in tissue regeneration. | 10-22-2015 |
Núria Degregorio-Rocasolano Barbany, Santa Coloma De Gramenet ES
Patent application number | Description | Published |
---|---|---|
20140323409 | APOTRANSFERRIN FOR THE TREATMENT OF BRAIN STROKE - The present invention relates to the use of apotransferrin for the preparation of a medicament for the treatment of brain stroke. Particularly the invention relates to the use of apotransferrin for the preparation of a medicament for the treatment of brain strokes wherein the drug prepared with apotransferrin is for administration by vascular route, preferably intravenous or intraarterial. | 10-30-2014 |
Núria García Gómez, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20120159873 | Composite Connection For A Wind Turbine Tower Structure - A tower section for a wind turbine tower structure comprises at least two shell segments defining, in an assembled condition, a substantially hollow structure, and including first connecting means for mutually joining two adjacent shell segments along a joint, which comprise a column of concrete arranged overlapping at least part of the joint between adjacent shell segments. A method for building a tower section for a wind turbine tower structure and a wind turbine comprising a nacelle having rotatable blades and a vertical tower made of at least one of such tower sections are further provided. | 06-28-2012 |
Núria Gavaldà Batalla, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20140296188 | NEW THERAPY FOR TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS - It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of trans-thyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate. | 10-02-2014 |
Núria Guilera Grandes, Mataro ES
Patent application number | Description | Published |
---|---|---|
20150152239 | FORMULATION OF INKS CONTAINING CERAMIC NANOPARTICLES - The present invention relates to formulations comprising aluminum nitride nanoparticles, at least one dispersant and at least one aqueous solvent, to the method for obtaining said formulations as well as to their use for obtaining a leveling barrier layer. | 06-04-2015 |
Núria Sierras Serra, Mataro ES
Patent application number | Description | Published |
---|---|---|
20150366194 | ATTRACTANT FOR FLIES OF THE SPECIES DROSOPHILA SUZUKII - The present invention is related to the use of compositions comprising an enzymatic hydrolysate of animal cartilage protein, at least one organic acid from an alcoholic fermentation, and water, as attractant for flies of the species | 12-24-2015 |
Núria Soldevilla Madrid, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20080312455 | Method For Determining Enantiomeric Purity Of Darifenacin And Intermediates - The present invention relates to a method for differentiating and quantifying the enantiomers, thereby determining the enantiomeric purity, of darifenacin and its intermediate compounds and salts thereof. In addition, the invention relates to a method for differentiating and quantifying the enantiomers, thereby determining the enantiomeric purity of compounds of formula (I): | 12-18-2008 |
20090018346 | Amorphous Form Of Darifenacin Hydrobromide And Processes For The Preparation Thereof - The present invention relates to amorphous form darifenacin hydrobromide and processes therefor. In addition, the present invention relates to compositions comprising amorphous form darifenacin hydrobromide. | 01-15-2009 |
20090247595 | Process for the preparation of tetrazolyl compounds - The invention provides a method for preparing candesartan cilexetil and related tetrazolyl compounds. More particularly, the invention relates to the preparation of candesartan cilexetil and related tetrazolyl compounds and includes a method of removing a protective group (e.g., triphenylmethane (trityl) protecting group) from an N-protected tetrazolyl compound using a Lewis acid in an inert solvent and in the presence of an alcohol (e.g., reacting an N-protected tetrazolyl compound with ZnCl | 10-01-2009 |
20090253746 | Synthesis and Preparations of Intermediates and New Polymorphs Thereof Useful For The Preparation Of Donepezil Hydrochlcoride - The invention relates to an improved process for preparing 2-(1-benzylpiperidin-4-ylmethyliden)-5,6-dimethoxyin-dan- | 10-08-2009 |
20090306406 | METHOD FOR PREPARING 1,3-DISUBSTITUTED PYRROLIDINE COMPOUNDS - A process for preparing substituted pyrrolidine compounds, including (5)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide, commonly known in the art as darifenacin, comprising reacting a pyrrolidine compound with a benzofuran derivative in the presence of a phase-transfer catalyst. | 12-10-2009 |
20120004239 | Process for Preparing Quinoxaline Derivatives - The present invention provides an improved process for preparing a compound of formula (IIIA), an intermediate of the synthesis of varenicline. Also, the present invention provides an improved process for preparing varenicline, or a pharmaceutically acceptable salt or solvate thereof. Furthermore, the present invention provides a process for decolorizing varenicline, or a salt or solvate thereof. Still further, the present invention provides a process of preparing varenicline L-tartrate with improved yield. Still further, the present invention relates to the use of compound of formula (V), or a salt or solvate thereof, as a reference marker and reference standard for assessing the purity of varenicline, or a salt or solvate thereof. | 01-05-2012 |
Núria Soldevilla Madrid, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090306406 | METHOD FOR PREPARING 1,3-DISUBSTITUTED PYRROLIDINE COMPOUNDS - A process for preparing substituted pyrrolidine compounds, including (5)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide, commonly known in the art as darifenacin, comprising reacting a pyrrolidine compound with a benzofuran derivative in the presence of a phase-transfer catalyst. | 12-10-2009 |